MedTrace Logo

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

NCT07062016 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-13

No results posted yet for this study

Summary

This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various hereditary or cancer specific genetic variants that may have a role in diagnosis or management and prognosis of cancer. It also seeks to develop a genetic results and medical record databank for future studies.

Conditions

  • Endometrial Carcinoma
  • Endometrial High Grade Endometrioid Adenocarcinoma
  • Stage II Endometrial Cancer
  • Stage III Endometrial Cancer
  • Stage IV Endometrial Cancer

Interventions

OTHER

Non-Interventional Study

Non-interventional study

Sponsors & Collaborators

Principal Investigators

  • Evelyn A. Reynolds, MD · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062016 on ClinicalTrials.gov